Next-generation Medical Affairs – Roche, Takeda, Eisai, Allergan, Ipsen…
How many people 20 years ago do you think would have believed you if you told them Medical Affairs is the future of pharma?
Such has been the growth of Medical’s stature over recent years, the function has grown from a supplementary to playing a vital role in pharma’s strategic plans, ambition and vision.
To stay ahead of this ever-increasing list of both external and internal demands and responsibilities, a new Medical operating model is a must – with each company’s approach their own.
In this 15-page white paper, you will gain insights from:
- Gavin Corcoran, CMO, Allergan
- Azmi Nabulsi, Dep. CMSO and Head, Strategic and Professional Affairs, Takeda
- Niko Andre, Head of Global Medical Affairs, Roche
- Kirk Shephard, SVP, Global Medical Affairs Oncology, Eisai
- Dr Sotirios Stergiopoulos, SVP Global Medical Affairs, Ipsen
- And many more medical affairs leaders…
You can get a free copy of the paper here: https://goo.gl/awFkyM
Such has been the growth of Medical’s stature over recent years, the function has grown from a supplementary to playing a vital role in pharma’s strategic plans, ambition and vision.
To stay ahead of this ever-increasing list of both external and internal demands and responsibilities, a new Medical operating model is a must – with each company’s approach their own.
In this 15-page white paper, you will gain insights from:
- Gavin Corcoran, CMO, Allergan
- Azmi Nabulsi, Dep. CMSO and Head, Strategic and Professional Affairs, Takeda
- Niko Andre, Head of Global Medical Affairs, Roche
- Kirk Shephard, SVP, Global Medical Affairs Oncology, Eisai
- Dr Sotirios Stergiopoulos, SVP Global Medical Affairs, Ipsen
- And many more medical affairs leaders…
You can get a free copy of the paper here: https://goo.gl/awFkyM
